warning

Alert: Because flu cases are on the rise, children 12 and younger will be restricted from visiting hospitals and certain inpatient facilities. Learn more.

Research and Clinical Trials

Title  
BMS CA209577: A Randomized, Multicenter, Double Blind, Phase III Study of Adjuvant Nivolumab or Placebo in Subjects with Resected Lower Esophageal, or Gastroesophageal Junction Cancer
Brief Description  
To compare OS of nivolumab versus placebo in subjects with resected EC or GEJ cancer. To compare DFS of nivolumab versus placebo in subjects with resected EC or GEJ cancer.
Who may be Eligible  
Please contact us for eligibility criteria.
Speciality/Disorder  
Esophagus
Status  
OPEN
Start Date  
12/01/2016
IRB Number  
00018041
Principal Investigator  
Hwang, Jimmy John
Contact Name  
Sandra Samu-Arce

For More Information, Contact  Sandra  , Samu-Arce
Phone:  980-993-5484 Fax:    
Email:  Sandra.SamuArce@carolinashealthcare.org
Address:1550 Faulk Street Suite 1500 Monroe, 28112
Close